Compounds > 11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid
Page last updated: 2024-09-04

11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid and Psychotic Disorders

11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid has been researched along with Psychotic Disorders in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hull, M; Medlin, H; Nussbaum, A; Rylander, M; Winston, HR1

Other Studies

1 other study(ies) available for 11-nor-delta(8)-tetrahydrocannabinol-9-carboxylic acid and Psychotic Disorders

ArticleYear
The association of cannabis use on inpatient psychiatric hospital outcomes.
    The American journal of drug and alcohol abuse, 2018, Volume: 44, Issue:1

    Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Dronabinol; Female; Hospitals, Psychiatric; Humans; Inpatients; Length of Stay; Male; Marijuana Use; Middle Aged; Patient Readmission; Psychotic Disorders; Treatment Outcome; Young Adult

2018